- Home
- CSAN vs JANX Comparison
CSAN vs JANX Comparison
Compare CSAN & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSAN
- JANX
- Stock Information
- Founded
- CSAN 1936
- JANX 2017
- Country
- CSAN Brazil
- JANX United States
- Employees
- CSAN N/A
- JANX N/A
- Industry
- CSAN Retail-Auto Dealers and Gas Stations
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- CSAN Consumer Discretionary
- JANX Health Care
- Exchange
- CSAN Nasdaq
- JANX Nasdaq
- Market Cap
- CSAN 2.3B
- JANX 2.2B
- IPO Year
- CSAN N/A
- JANX 2021
- Fundamental
- Price
- CSAN $5.13
- JANX $36.01
- Analyst Decision
- CSAN Strong Buy
- JANX Strong Buy
- Analyst Count
- CSAN 1
- JANX 11
- Target Price
- CSAN $19.00
- JANX $83.09
- AVG Volume (30 Days)
- CSAN 1.2M
- JANX 852.9K
- Earning Date
- CSAN 02-26-2025
- JANX 03-07-2025
- Dividend Yield
- CSAN 6.75%
- JANX N/A
- EPS Growth
- CSAN N/A
- JANX N/A
- EPS
- CSAN 0.22
- JANX N/A
- Revenue
- CSAN $7,655,547,290.00
- JANX $13,049,000.00
- Revenue This Year
- CSAN $330.06
- JANX $39.66
- Revenue Next Year
- CSAN $2.09
- JANX N/A
- P/E Ratio
- CSAN $5.80
- JANX N/A
- Revenue Growth
- CSAN 3.43
- JANX 54.12
- 52 Week Low
- CSAN $4.95
- JANX $14.84
- 52 Week High
- CSAN $14.81
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- CSAN 44.38
- JANX 34.78
- Support Level
- CSAN $5.24
- JANX $36.13
- Resistance Level
- CSAN $5.64
- JANX $38.13
- Average True Range (ATR)
- CSAN 0.17
- JANX 2.52
- MACD
- CSAN 0.02
- JANX 0.08
- Stochastic Oscillator
- CSAN 26.28
- JANX 5.71
About CSAN Cosan S.A. ADS
Cosan SA engages in several services throughout the energy and logistics sectors. Its reportable segments are Raizen, Compass, Moove, Rumo, and Radar. It generates the majority of its revenue from Raizen which operates in the production, commercialization, origination, and trading of ethanol, bioenergy, resale, and trading of electricity, renewable sources, marketing, origination, and trading of sugar and fuels, and lubricant.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.